CYCN · ISSUER CIK 1755237
Cyclerion Therapeutics, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 2 Cyclerion Therapeutics, Inc. insiders reported $0.00 of open-market purchases and $0.00 of sales on SEC Form 4.
↗2 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$0.00Insider buying
$0.00Insider selling
$0.00Net open-market
Aug 18, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 18, 202617:27 | Aug 14, 2026 | CYCN | Chief Financial Officer | M · Exercise | $2.36 | +25,000 | 25,018 | +138889% | $59K | ||
| Aug 18, 202617:21 | Aug 14, 2026 | CYCN | See Remarks, Director | M · Exercise | $3.30 | +55,849 | 156,152 | +56% | $184K | ||
| Aug 18, 202617:21 | Aug 14, 2026 | CYCN | See Remarks, Director | F · Tax | $3.79 | −48,629 | 107,523 | -31% | $184K |